EASTHAM KARIN
SEC CIK 1231845 · EDGAR
BoughtSold
Most active insiders at VCYT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stapley Marc | CEO, Dir | — | $8.92M |
| 2 | JONES EVAN/ FA | Dir | — | $2.00M |
| 3 | Chambers Rebecca | CFO | — | $1.91M |
| 4 | McGuire Annie | SVP, GC | — | $1.80M |
| 5 | Wygant Jonathan | VP, CAO | — | $1.54M |
| 6 | EASTHAM KARIN | Dir | — | $1.49M |
| 7 | Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| 8 | Leite John | Gbl Chief Commercial Off | — | $1.34M |
| 9 | EPSTEIN ROBERT S | Dir | — | $1.19M |
| 10 | Holstein Jens | Dir | — | $628.3K |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-22 16:30 | 2026-06-18 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $52.89 | -3,729 | 15.1K | -20% | -$197.2K |
| 2026-06-15 16:56 | 2026-06-11 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +5,272 | 18.8K | +39% | $0 | |
| A | 2026-06-11 16:30 | 2026-05-12 | PSNL | Personalis, Inc. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +6,250 | 19.8K | +46% | $0 |
| D | 2026-05-14 17:09 | 2026-05-12 | PSNL | Personalis, Inc. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +6,250 | 22.4K | +39% | $0 |
| DM | 2025-12-08 | 2025-12-05 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | M - OptEx | $7.77 | +20.0K | 33.6K | +148% | +$155.4K |
| DM | 2025-12-08 | 2025-12-05 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale+OE | $45.45 | -20.0K | 27.2K | -42% | -$909.0K |
| 2025-11-07 | 2025-11-05 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $40.02 | -9,674 | 13.6K | -42% | -$387.2K | |
| 2025-06-23 | 2025-06-18 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +9,321 | 23.2K | +67% | $0 | |
| 2025-06-17 | 2025-06-13 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $26.66 | -4,590 | 13.9K | -25% | -$122.4K | |
| DM | 2025-01-06 | 2025-01-02 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale+OE | $40.30 | -10.0K | 23.2K | -30% | -$403.0K |
| D | 2025-01-06 | 2025-01-02 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | M - OptEx | $5.28 | +10.0K | 28.5K | +54% | +$52.8K |
| M | 2024-11-21 | 2024-11-19 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $38.34 | -14.7K | 18.5K | -44% | -$564.8K |
| 2024-07-18 | 2024-07-16 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $25.00 | -7,500 | 33.2K | -18% | -$187.5K | |
| 2024-06-17 | 2024-06-13 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +11.5K | 40.7K | +39% | $0 | |
| 2024-06-13 | 2024-06-11 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $20.59 | -3,870 | 29.3K | -12% | -$79.7K | |
| D | 2024-06-11 | 2024-06-07 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | M - OptEx | $10.41 | +2,500 | 35.6K | +8% | +$26.0K |
| D | 2024-06-11 | 2024-06-07 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale+OE | $20.97 | -2,500 | 33.1K | -7% | -$52.4K |
| D | 2024-04-02 | 2024-04-01 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale+OE | $21.65 | -10.0K | 33.1K | -23% | -$216.5K |
| D | 2024-04-02 | 2024-04-01 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | M - OptEx | $13.19 | +10.0K | 43.1K | +30% | +$131.9K |
| 2023-06-13 | 2023-06-09 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +9,674 | 33.1K | +41% | $0 | |
| D | 2023-03-17 | 2023-03-16 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale+OE | $22.78 | -18.8K | 23.5K | -44% | -$427.1K |
| D | 2023-03-17 | 2023-03-16 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | M - OptEx | $12.12 | +18.8K | 42.2K | +80% | +$227.2K |
| D | 2023-03-02 | 2023-02-28 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale+OE | $25.00 | -10.0K | 23.5K | -30% | -$250.0K |
| D | 2023-03-02 | 2023-02-28 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | M - OptEx | $12.12 | +10.0K | 33.5K | +43% | +$121.2K |
| D | 2023-01-17 | 2023-01-13 | GERN | GERON CORP | EASTHAM KARIN | Dir | M - OptEx | $1.10 | +35.0K | 109.0K | +47% | +$38.5K |
| D | 2022-09-20 | 2022-09-16 | NKTR | NEKTAR THERAPEUTICS | EASTHAM KARIN | Dir | A - Grant | $0.00 | +10.2K | 23.2K | +78% | $0 |
| 2022-09-14 | 2022-09-13 | NKTR | NEKTAR THERAPEUTICS | EASTHAM KARIN | Dir | S - Sale | $3.61 | -21.3K | 13.0K | -62% | -$76.8K | |
| 2022-06-16 | 2022-06-16 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +14.7K | 23.5K | +169% | $0 | |
| D | 2022-05-19 | 2022-05-17 | PSNL | Personalis, Inc. | EASTHAM KARIN | Dir | A - Grant | $0.00 | +10.8K | 13.5K | +394% | $0 |
| D | 2022-04-21 | 2022-04-20 | GERN | GERON CORP | EASTHAM KARIN | Dir | M - OptEx | $1.41 | +35.0K | 74.0K | +90% | +$49.4K |
| D | 2021-12-20 | 2021-12-17 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | M - OptEx | $12.12 | +5,000 | 13.7K | +57% | +$60.6K |
| D | 2021-12-20 | 2021-12-17 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale+OE | $45.00 | -5,000 | 8,720 | -36% | -$225.0K |
| MIE | 2021-11-03 | 2021-11-01 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $32,978.71 | -4,400 | 1,241 | -78% | — |
| D | 2021-09-24 | 2021-09-22 | NKTR | NEKTAR THERAPEUTICS | EASTHAM KARIN | Dir | A - Grant | $0.00 | +10.2K | 34.3K | +42% | $0 |
| MI | 2021-08-04 | 2021-08-02 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Dir | S - Sale | $43.90 | -4,400 | 5,954 | -42% | -$193.2K |
Purchase Sale Sale after option exercise All abbreviations